Autolomous

Autolomous enables cell & gene therapy (CGT) manufacturers to deliver personalised medicine treatments to more patients worldwide. We provide manufacturers with ways to scale their operations by deploying a fully integrated and digitised platform, autoloMATE, which allows customers to book, make, and deliver CGT treatments. We have successfully integrated with over 25 external systems from key suppliers within the industry, creating a seamless, connected ecosystem. Using our intuitive solutions, all types of CGTs can be made 40% more efficient while ensuring compliance, safety, and affordability. Our clients span Academia, CDMOs, and Biotech in the UK, Europe, and the US.